GENTILINI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.809
EU - Europa 7.675
AS - Asia 1.583
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 4
Totale 23.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.769
RU - Federazione Russa 2.868
SE - Svezia 1.002
IE - Irlanda 978
PL - Polonia 795
UA - Ucraina 577
SG - Singapore 557
IT - Italia 500
HK - Hong Kong 453
DE - Germania 359
FI - Finlandia 270
CN - Cina 223
GB - Regno Unito 162
IN - India 146
TR - Turchia 136
CH - Svizzera 71
CI - Costa d'Avorio 62
JO - Giordania 46
CA - Canada 37
FR - Francia 36
BE - Belgio 23
NL - Olanda 17
SC - Seychelles 15
VN - Vietnam 12
KR - Corea 7
LT - Lituania 6
CZ - Repubblica Ceca 4
EU - Europa 4
MX - Messico 3
NZ - Nuova Zelanda 3
BR - Brasile 2
EG - Egitto 2
ES - Italia 2
MU - Mauritius 2
AT - Austria 1
AU - Australia 1
CL - Cile 1
EE - Estonia 1
IR - Iran 1
JP - Giappone 1
NO - Norvegia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 23.160
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.759
Fairfield 1.224
Chandler 1.085
Dublin 977
Jacksonville 918
Warsaw 794
Woodbridge 594
Ashburn 585
Cambridge 565
Seattle 545
Wilmington 453
Houston 439
Singapore 439
Princeton 264
Ann Arbor 250
Hong Kong 231
Boardman 200
Boston 191
Buffalo 185
Mumbai 127
Medford 124
Lawrence 121
Altamura 116
Izmir 107
Beijing 96
San Diego 72
Bern 70
Norwalk 66
Abidjan 62
Shanghai 51
Dearborn 47
Milan 39
Moscow 37
Andover 32
Hillsboro 31
Falls Church 30
Florence 29
Kent 29
Los Angeles 28
Auburn Hills 27
New York 27
Toronto 26
Bremen 25
Frankfurt Am Main 24
Brussels 23
West Jordan 22
Verona 19
Washington 17
Salerno 15
Yubileyny 15
Guangzhou 11
Dong Ket 10
Laurel 9
London 9
Rome 9
Saint Petersburg 7
Munich 6
Nanjing 6
Philadelphia 6
Pune 6
Redmond 6
Bagno a Ripoli 5
Kunming 5
Phoenix 5
Tappahannock 5
Brno 4
Catania 4
Changsha 4
Frankfurt am Main 4
Helsinki 4
Las Vegas 4
Ottawa 4
San Mateo 4
Taranto 4
Caserta 3
Grevenbroich 3
Kumeu 3
Old Bridge 3
Redwood City 3
Riardo 3
Seoul 3
Ahmedabad 2
Brescia 2
Cairo 2
Chicago 2
Empoli 2
Kolkata 2
Lappeenranta 2
Mantova 2
Meppel 2
Modena 2
Modica 2
Montréal 2
Naaldwijk 2
New Delhi 2
Qingdao 2
Reynosa 2
Rivoli 2
Rufina 2
Salamanca 2
Totale 14.452
Salva come PNG Salva come JPEG
Nome #
Serum hepatitis delta virus RNA in patients with delta hepatitis and in liver graft recipients 1.130
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 271
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 253
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 242
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 239
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx 229
Fat-storing cells as liver-specific pericytes: spatial dynamic of agonist-stimulated intracellular calcium transients. 219
SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED BY PERCUTANEOUS ETHANOL INJECTION: A 10-YEAR EXPERIENCE. 148
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells 142
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 141
Bile acid inhibition of p-glycoprotein mediated transport in multidrug resistant cells and rat liver canalicular membrane vesicles 138
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 138
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 137
Amplification of hepatitis delta virus RNA sequences by polymerase chain reaction: a tool for viral detection and cloning 134
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 133
Defective aggregation in cirrhosis is independent of in vivo platelet activation. 131
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 129
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 127
Altered cardiovascular responsiveness to active tilting in nonalcoholic cirrhosis. 126
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 123
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 123
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 120
Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients 120
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 120
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 119
Ascites and hepatorenal syndrome 118
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 117
Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites. 117
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 117
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 116
Infection of peripheral mononuclear blood cells by hepatitis C virus 115
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 115
T(14;18) translocation in chronic hepatitis C virus infection 114
Torasemide in the treatment of patients with cirrhosis and ascites. 113
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 113
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 112
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 112
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 111
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 111
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 111
Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. 110
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation 109
Patterns and mechanisms of hepatitis B/hepatitis D reinfection after liver transplantation 109
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 109
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 109
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 109
Loop diuretic therapy in liver cirrhosis with ascites 108
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 108
Analysis of HCV persistence in patients with sustained virological response 108
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 108
Expression of platelet-derived growth factor in a model of acute liver injury. 107
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 106
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 106
Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis 105
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 105
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 105
The cellular and molecular basis of liver fibrogenesis. 104
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 104
Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists 104
Fibrogenesi epatica: valutazione dell'espressione genica di citochine fibrogeniche e dei tipi più rappresentanti di collagene. 103
Uveitis in autoimmune hepatitis: a case report. 103
HCV infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma. 103
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role 103
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. 103
Respiratory mechanics in patients with tense cirrhotic ascites. 103
HCV INFECTION OF PERIPHERAL AND LIVER MONONUCLEAR-CELLS - PATHOGENIC IMPLICATIONS 102
Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation. 102
Multiple biological effects of endothelin-1 in fat-storing cells isolated from human liver. 101
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 100
Pathogenesis and treatment of ascites in hepatic cirrhosis. 100
Changes in the production of nitric oxide and superoxide by inflammatory cells in liver cirrhosis. 100
Hepatitis C virus lymphotropism and possible pathogenetic implications 99
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure. 99
Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. 99
Pathogenesis and management of the hepatorenal syndrome. 99
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 98
Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. 98
Alterazioni del sistema pPAF-AH/PAF in pazienti con infezione cronica da HCV 98
Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and non alcoholic liver disease. 97
Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis 97
Pathogenesis and treatment of ascites in hepatic cirrhosis. 97
Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. 96
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 96
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 95
Molecular mechanism underlying impaired platelet responsiveness in liver cirrhosis 95
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 95
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications 94
Renal functional impairment and sodium retention in liver cirrhosis. 94
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 94
Polymerase chain reaction for hepatitis delta virus RNA identification and characterization 94
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection 92
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. 92
Crioglobulinemia e linfoma in corso di infezione da HCV 92
Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. 92
Chemotherapy of primary and secondary liver cancer: is it useful? 91
Interstitial lung fibrosis in patients with hepatitis C virus infection 91
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 91
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 91
Defective signal transduction in platelets from cirrhotic patients is associated with increased cyclic AMP and cyclic GMP content. 90
Hemodynamic, renal and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis 90
Totale 12.646
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.456
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.456
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.176 0 0 0 0 282 414 325 413 260 174 262 46
2020/20212.068 202 88 213 194 57 336 37 197 151 279 134 180
2021/20221.574 25 192 46 72 42 51 49 80 66 42 380 529
2022/20234.195 429 428 201 320 435 841 572 250 469 28 120 102
2023/20241.257 65 180 278 79 77 147 35 263 23 31 41 38
2024/20257.078 307 1.102 734 1.580 3.355 0 0 0 0 0 0 0
Totale 23.204